{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:49:26Z","timestamp":1792000166805,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T00:00:00Z","timestamp":1589846400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Journal"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.bj.2020.05.003","type":"journal-article","created":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T02:39:21Z","timestamp":1590201561000},"page":"368-374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Repurposing old drugs as antiviral agents for coronaviruses"],"prefix":"10.1016","volume":"43","author":[{"given":"Cheng-Wei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Ting","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsing-Yu","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Zhi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szu-Huei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hsing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Yu","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsu-An","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng-Kuang","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Zheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiunn-Horng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huey-Kang","family":"Sytwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiung-Tong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4012-0149","authenticated-orcid":false,"given":"Shiow-Ju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bj.2020.05.003_bib1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/tmi.13383","article-title":"The COVID-19 epidemic","volume":"25","author":"Velavan","year":"2020","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.bj.2020.05.003_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000003","article-title":"Why are RNA virus mutation rates so damn high?","volume":"16","author":"Duffy","year":"2018","journal-title":"PLoS Biol"},{"key":"10.1016\/j.bj.2020.05.003_bib3","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3390\/v10110600","article-title":"RNA virus fidelity mutants: a useful tool for evolutionary biology or a complex challenge?","volume":"10","author":"Kautz","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.bj.2020.05.003_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/path.4454","article-title":"Molecular pathology of emerging coronavirus infections","volume":"235","author":"Gralinski","year":"2015","journal-title":"J Pathol"},{"key":"10.1016\/j.bj.2020.05.003_bib5","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00023-19","article-title":"High-throughput screening and identification of potent broad-spectrum inhibitors of coronaviruses","volume":"93","author":"Shen","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.bj.2020.05.003_bib6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.antiviral.2010.08.009","article-title":"Identification of phenanthroindolizines and phenanthroquinolizidines as novel potent anti-coronaviral agents for porcine enteropathogenic coronavirus transmissible gastroenteritis virus and human severe acute respiratory syndrome coronavirus","volume":"88","author":"Yang","year":"2010","journal-title":"Antivir Res"},{"key":"10.1016\/j.bj.2020.05.003_bib7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.taap.2017.04.017","article-title":"Identification of anti-viral activity of the cardenolides, Na(+)\/K(+)-ATPase inhibitors, against porcine transmissible gastroenteritis virus","volume":"332","author":"Yang","year":"2017","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.bj.2020.05.003_bib8","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.taap.2018.07.028","article-title":"The cardenolide ouabain suppresses coronaviral replication via augmenting a Na(+)\/K(+)-ATPase-dependent PI3K_PDK1 axis signaling","volume":"356","author":"Yang","year":"2018","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.bj.2020.05.003_bib9","doi-asserted-by":"crossref","first-page":"10363","DOI":"10.1021\/jm300705j","article-title":"Synthesis and biological evaluation of tylophorine-derived dibenzoquinolines as orally active agents: exploration of the role of tylophorine e ring on biological activity","volume":"55","author":"Lee","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bj.2020.05.003_bib10","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3390\/v10120721","article-title":"Development of small-molecule MERS-CoV inhibitors","volume":"10","author":"Liang","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.bj.2020.05.003_bib11","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1128\/AAC.48.7.2693-2696.2004","article-title":"Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide","volume":"48","author":"Wu","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bj.2020.05.003_bib12","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.bbrc.2004.04.083","article-title":"HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus","volume":"318","author":"Yamamoto","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bj.2020.05.003_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/ecam\/neh081","article-title":"Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3'-digallate (TF3).","volume":"2","author":"Chen","year":"2005","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.bj.2020.05.003_bib14","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2217\/fvl.11.33","article-title":"Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy","volume":"6","author":"Barnard","year":"2011","journal-title":"Future Virol"},{"key":"10.1016\/j.bj.2020.05.003_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.tmaid.2019.06.012","article-title":"A systematic review of therapeutic agents for the treatment of the Middle East respiratory syndrome coronavirus (MERS-CoV)","volume":"30","author":"Momattin","year":"2019","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.bj.2020.05.003_bib16","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/infdis\/jiv392","article-title":"Treatment with lopinavir\/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset","volume":"212","author":"Chan","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bj.2020.05.003_bib17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1292\/jvms.54.557","article-title":"The prevalence of types I and II feline coronavirus infections in cats","volume":"54","author":"Hohdatsu","year":"1992","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.bj.2020.05.003_bib18","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2460\/ajvr.1976.37.12.1449","article-title":"Serologic studies of naturally occurring feline infectious peritonitis","volume":"37","author":"Pedersen","year":"1976","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.bj.2020.05.003_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jfms.2003.11.001","article-title":"Human severe acute respiratory syndrome (SARS) and feline coronaviruses","volume":"6","author":"Paltrinieri","year":"2004","journal-title":"J Feline Med Surg"},{"key":"10.1016\/j.bj.2020.05.003_bib20","doi-asserted-by":"crossref","first-page":"11325","DOI":"10.1128\/JVI.05512-11","article-title":"Molecular epidemiology of human coronavirus OC43 reveals evolution of different genotypes over time and recent emergence of a novel genotype due to natural recombination","volume":"85","author":"Lau","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.bj.2020.05.003_bib21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/diseases4030026","article-title":"Human coronaviruses: a review of virus-host interactions","volume":"4","author":"Lim","year":"2016","journal-title":"Diseases"},{"key":"10.1016\/j.bj.2020.05.003_bib22","doi-asserted-by":"crossref","first-page":"104762","DOI":"10.1016\/j.antiviral.2020.104762","article-title":"Of chloroquine and COVID-19","volume":"177","author":"Touret","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.bj.2020.05.003_bib23","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.vetmic.2018.04.026","article-title":"The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies","volume":"219","author":"Murphy","year":"2018","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.bj.2020.05.003_bib24","doi-asserted-by":"crossref","first-page":"100128","DOI":"10.1016\/j.onehlt.2020.100128","article-title":"Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses","volume":"9","author":"Amirian","year":"2020","journal-title":"One health"},{"key":"10.1016\/j.bj.2020.05.003_bib25","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe Covid-19","volume":"382","author":"Grein","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bj.2020.05.003_bib26","first-page":"145","article-title":"Isolation and identification of a novel feline coronavirus from a kitten with naturally occurring feline infectious peritonitis in Taiwan","volume":"35","author":"Lin","year":"2009","journal-title":"Taiwan Vet J"},{"key":"10.1016\/j.bj.2020.05.003_bib27","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.bj.2020.05.003_bib28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/ph13030051","article-title":"Emetine, ipecac, ipecac alkaloids and analogues as potential antiviral agents for coronaviruses","volume":"13","author":"Bleasel","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bj.2020.05.003_bib29","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.clml.2013.03.017","article-title":"Homoharringtonine\/omacetaxine mepesuccinate: the long and winding road to food and drug administration approval","volume":"13","author":"Kantarjian","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.bj.2020.05.003_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124595","article-title":"Repurposing salicylanilide anthelmintic drugs to combat drug resistant Staphylococcus aureus","volume":"10","author":"Rajamuthiah","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.bj.2020.05.003_bib31","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1128\/AAC.45.5.1473-1479.2001","article-title":"Activities and conformational fitting of 1,4-naphthoquinone derivatives and other cyclic 1,4-diones tested in\u00a0vitro against Pneumocystis carinii","volume":"45","author":"Ball","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bj.2020.05.003_bib32","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1161\/hc4501.099313","article-title":"Acute hemodynamic effects of conivaptan, a dual V(1A) and V(2) vasopressin receptor antagonist, in patients with advanced heart failure","volume":"104","author":"Udelson","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.bj.2020.05.003_bib33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.6026\/97320630016236","article-title":"Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus","volume":"16","author":"Odhar","year":"2020","journal-title":"Bioinformation"},{"key":"10.1016\/j.bj.2020.05.003_bib34","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jcrc.2020.03.005","article-title":"A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19","volume":"57","author":"Cortegiani","year":"2020","journal-title":"J Crit Care"},{"key":"10.1016\/j.bj.2020.05.003_bib35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.dsx.2020.03.011","article-title":"Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: a systematic search and a narrative review with a special reference to India and other developing countries","volume":"14","author":"Singh","year":"2020","journal-title":"Diabetes Metabol Syndrome"},{"key":"10.1016\/j.bj.2020.05.003_bib36","doi-asserted-by":"crossref","first-page":"156","DOI":"10.5582\/bst.2020.03072","article-title":"Update on use of chloroquine\/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19)","volume":"14","author":"Gao","year":"2020","journal-title":"Biosci Trends"},{"key":"10.1016\/j.bj.2020.05.003_bib37","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/j.bmcl.2012.02.105","article-title":"Synthesis and antiviral activity of a series of 1'-substituted 4-aza-7,9-dideazaadenosine C-nucleosides","volume":"22","author":"Cho","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bj.2020.05.003_bib38","doi-asserted-by":"crossref","first-page":"104760","DOI":"10.1016\/j.antiviral.2020.104760","article-title":"The broad spectrum antiviral ivermectin targets the host nuclear transport importin \u03b1\/\u03b21 heterodimer","volume":"177","author":"Yang","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.bj.2020.05.003_bib39","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"}],"container-title":["Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417020300664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417020300664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:07:18Z","timestamp":1762420038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2319417020300664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S2319417020300664"],"URL":"https:\/\/doi.org\/10.1016\/j.bj.2020.05.003","relation":{},"ISSN":["2319-4170"],"issn-type":[{"value":"2319-4170","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing old drugs as antiviral agents for coronaviruses","name":"articletitle","label":"Article Title"},{"value":"Biomedical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bj.2020.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Chang Gung University. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}